The influence of a polymorphism at position -857 of the tumour necrosis factor alpha gene on clinical response to etanercept therapy in rheumatoid arthritis. [electronic resource]
Producer: 20050524Description: 547-52 p. digitalISSN:- 1462-0324
- Adult
- Antirheumatic Agents -- therapeutic use
- Arthritis, Rheumatoid -- drug therapy
- Etanercept
- Female
- Genetic Markers
- Genotype
- Haplotypes
- Humans
- Immunoglobulin G -- therapeutic use
- Lymphotoxin-alpha -- genetics
- Male
- Middle Aged
- Polymorphism, Single Nucleotide
- Receptors, Tumor Necrosis Factor -- therapeutic use
- Treatment Outcome
- Tumor Necrosis Factor-alpha -- antagonists & inhibitors
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.